Ledger.Open graph →
SEC Form D · filed July 7, 2021

Aliada Therapeutics, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Adam J. Rosenberg · Boston, MAExec · DirectorLaura J. Tadvalkar · Boston, MADirectorSari Epstein · Boston, MAExecTristan Wilkerson · Washington, Washington, D.C.Exec · DirectorDavid Friedlaender · Belleair, FLDirectorScott Deffebach · Highland Village, TXExecBahram A. Motamedian · SAN ANTONIO, TXExec · DirectorRachel A. Donnelly · SAN ANTONIO, TXExecAndra Purkalitis · SAN ANTONIO, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗